Purpose
This study aimed to explore the functions and mechanisms of C-C motif chemokine receptor 6 (CCR6), a gene associated with progression and metastasis of colorectal cancer (CRC), in radiosensitivity of rectal cancer (RC).
Materials and Methods
RNA sequencing and immunohistochemical analysis on CCR6 expression were performed in pretreatment tissues of RC patients exhibiting different therapeutic effects of radiotherapy. Colonogenic survival assay was conducted in different CRC cell lines to assess their radiosensitivity. And the impact of CCR6 expression on radiosensitivity was validated through RNA interference. The DNA damage repair (DDR) abilities of cell lines with different CCR6 expression were evaluated through immunofluorescence-based γH2AX quantification.
Results
The CCR6 mRNA level was higher in patients without pathologic complete remission (pCR) than in those with pCR (fold changed, 2.11; p=0.004). High-level expression of CCR6 protein was more common in the bad responders than in the good responders (76.3% vs. 37.5%, p < 0.001). The CRC cell lines with higher CCR6 expression (LoVo and sw480) appeared to be more radioresistant, compared with the sw620 cell line which had lower CCR6 expression. CCR6 knockdown made the LoVo cells more sensitive to ionizing radiation (sensitization enhancement ratio, 1.738; p < 0.001), and decreased their DDR efficiency.
Conclusion
CCR6 might affect the RC radiosensitivity through DDR process. These findings supported CCR6 as a predicting biomarker of radiosensitivity and a potential target of radiosensitization for RC patients.
Citations
Citations to this article as recorded by
Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells Josiane W. Tessmann, Murilo R. Rocha, Jose A. Morgado‐Díaz Journal of Cellular Biochemistry.2023; 124(1): 31. CrossRef
Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis Ji Min Park, Shin Kim, Sung Uk Bae, Sang Jun Byun, Incheol Seo, Hye Won Lee Journal of Korean Medical Science.2023;[Epub] CrossRef
Radiotherapy resistance: identifying universal biomarkers for various human cancers Irina Larionova, Militsa Rakina, Elena Ivanyuk, Yulia Trushchuk, Alena Chernyshova, Evgeny Denisov Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1015. CrossRef
Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models Moying Li, Qiyun Xiao, Nachiyappan Venkatachalam, Ralf-Dieter Hofheinz, Marlon R. Veldwijk, Carsten Herskind, Matthias P. Ebert, Tianzuo Zhan Therapeutic Advances in Medical Oncology.2022;[Epub] CrossRef
131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry Pedro Cruz-Nova, Blanca Ocampo-García, Dayan Andrea Carrión-Estrada, Paola Briseño-Diaz, Guillermina Ferro-Flores, Nallely Jiménez-Mancilla, José Correa-Basurto, Martiniano Bello, Libia Vega-Loyo, María del Rocío Thompson-Bonilla, Rosaura Hernández-Rivas, Molecules.2022; 27(17): 5446. CrossRef
Regulation of pancreatic cancer therapy resistance by chemokines Shailendra K. Gautam, Soumi Basu, Abhijit Aithal, Nidhi V. Dwivedi, Mansi Gulati, Maneesh Jain Seminars in Cancer Biology.2022; 86: 69. CrossRef
Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer Yuhong Chen, Biao Yang, Mingyang Chen, Zhaojun Li, Zhengyin Liao Frontiers in Bioscience-Landmark.2022;[Epub] CrossRef
Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review Marzia Mare, Lorenzo Colarossi, Veronica Veschi, Alice Turdo, Dario Giuffrida, Lorenzo Memeo, Giorgio Stassi, Cristina Colarossi Genes.2021; 12(10): 1502. CrossRef
ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer Lin He, Hao Chang, Yuhong Qi, Bing Zhang, Qiuju Shao Technology in Cancer Research & Treatment.2021;[Epub] CrossRef
Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model Noraini Nordin, Swee Keong Yeap, Heshu Sulaiman Rahman, Nur Rizi Zamberi, Nurul Elyani Mohamad, Nadiah Abu, Mas Jaffri Masarudin, Rasedee Abdullah, Noorjahan Banu Alitheen Molecules.2020; 25(11): 2670. CrossRef
Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells Xiaofei Li, Ruifang Tian, Lan Liu, Lihui Wang, Dong He, Ke Cao, John K. Ma, Chenghui Huang Journal of International Medical Research.2020;[Epub] CrossRef
Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line Cinzia Antognelli, Isabella Palumbo, Simonetta Piattoni, Monica Calzuola, Beatrice Del Papa, Vincenzo N. Talesa, Cynthia Aristei International Journal of Radiation Biology.2020; 96(11): 1504. CrossRef
The expression of long noncoding RNA CRCAL‐3 in colorectal cancer and its impacts on cell proliferation and migration Hui Chang, Guan‐Nan Wang, Ya‐Lan Tao Journal of Cellular Biochemistry.2019; 120(9): 15369. CrossRef
Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease Ranmali Ranasinghe, Rajaraman Eri Medicines.2018; 5(3): 69. CrossRef
Autophagy-regulating microRNAs: potential targets for improving radiotherapy Hongbin Li, Xiaodong Jin, Bing Chen, Ping Li, Qiang Li Journal of Cancer Research and Clinical Oncology.2018; 144(9): 1623. CrossRef